Global Epilepsy Drugs Market Size - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Epilepsy Drugs Market Size

Description:

According to a report published by Renub Research, Global Epilepsy Drugs Market is anticipated to be more than USD 9 Billion opportunity for pharmaceutical companies by 2025. Epilepsy drugs are generally termed as anti-seizure or anticonvulsants drugs which are used for the symptomatic treatment of epilepsy. Epilepsy drugs act as a mood stabilizers and so it is used in the treatment of bipolar disorder or neuropathic pain. For More Information: – PowerPoint PPT presentation

Number of Views:3

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Epilepsy Drugs Market Size


1
Global Epilepsy Drugs Market

2
Report Description and Highlights
Analyst View According to Renub Research
analysis Global Epilepsy Drugs Market is
anticipated to be more than USD 9
Billion opportunity for pharmaceutical companies
by 2025. Epilepsy is a neurological (central
nervous system) disorder which affects the brain
activity, causing seizures or involuntary
episodes of unusual behavior, shaking a part or
complete body and sometimes loss of awareness.
The epilepsy patient may experience commotion of
consciousness and movements along with sensory or
psychiatric disorders. Anyone can develop
epilepsy, irrespective of gender, age, and race,
and can cause other health ailments also. It is
the fourth most common cause of neurological
disorder across the world and on an estimate
there are nearly 24 million people suffering from
epilepsy worldwide, creating immense opportunity
for the research and development of
anti-epileptic drugs. This report talks about
the upcoming Epilepsy Drugs Market its future
potential and drugs going through its clinical
trial phases. The report also provides insights
on the key factors that are driving the market
growth and challenges which are restraining the
market growth.


3
Global Epilepsy Drugs Market
People suffering from epilepsy may have more
than one type of seizure and have other
neurological disorder as well. Hence, to
determine the treatment given, some of the common
diagnostic tests for epilepsy patients include
EEG (electroencephalogram) testing, family
history, and clinical history. Epilepsy drugs
(antiepileptic drugs) are medicines that are
approved to treat epilepsy patients.
Antiepileptic medicines (AEDs) are prescribed
considering type and seriousness of seizure, the
age of the patient and the part of the brain
involved. Lyrica one of the leading antiepileptic
brands, due to its efficacy, is widely
recommended in treating epilepsy disorder.
However, recently approved epilepsy drugs
(Perampanel and Retigabine) are also driving the
epilepsy drugs market as these drugs act through
new molecular targets.   Epilepsy drugs are
generally termed as anti-seizure or
anticonvulsants drugs which are used for the
symptomatic treatment of epilepsy. Epilepsy drugs
act as a mood stabilizers and so it is used in
the treatment of bipolar disorder or neuropathic
pain. Though the cause of epilepsy is unclear,
some of the major factors causing epilepsy
include brain tumor, brain injury, stroke, and
substance use disorder. Changing lifestyle,
smoking, alcoholism and growing geriatric
population are among the leading factors that are
driving the epilepsy drugs market. 

4
Global Epilepsy Drugs Market
In addition, owing to the approvals of new drugs
for epilepsy further expected to boost the growth
of epilepsy drugs market over the forecast
period. On the other hand, recent patent
expiration of major brands offers massive
opportunity for the generic drugs to come up in
the market. It is expected that due to the recent
and in future patent expiration of major brands,
the epilepsy drugs market would become very much
competitive and the prices of branded drugs would
come down, which is expected to hinder the growth
of Epilepsy Drugs Market in the near future.
Read more here https//www.renub.com/epilepsy-
drugs-market-p.php

5
Epilepsy Market Share By Drugs
Global Forecast for Epilepsy Market Share By
Drugs (Percent), 2019 - 2025

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
6
Global Epilepsy Drugs Market Summary
  • Market Summary
  • By Country United States dominaties the
    epilepsy drugs market. US market share is
    expected to grow due to the better healthcare
    support system, growing awareness increasing
    per capita healthcare expenditure. This report
    covers the market and market share of the United
    States, United Kingdom, France, Germany, Italy,
    Spain, India, China and Japan.
  • Drugs Category By Generation Second and
    Third generation drugs are having a big market
    share. This research report provides market and
    market share of First, Second, Third generation
    drugs.
  • By Drugs Vimpat (Lacosamide) and Keppra
    (Levetiracetam) are holding big market share.
    Following drugs are covered in this report,
    Vimpat (Lacosamide), Keppra (Levetiracetam),
    Sabril (Vigabatrin), Onfi (Clobazam), Fycompa,
    Briviact (Brivaracetam), Epidiolex and Cenobamate
    (YKP3089).
  • By Companies The report provides overview,
    initiatives and financial insights of Eisai Co.
    Ltd, UCB Inc., H. Lundbeck A/S and GW
    Pharmaceuticals Plc.
  • Request a free sample copy of the
    report https//www.renub.com/request-sample-page.
    php?gturlepilepsy-drugs-market-p.php


7
Global Epilepsy Drugs Market 2019 - 2025

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
8
Key Topics Covered in Global Epilepsy Drugs Market
1.    Introduction 1.1    Market Definition 1.2
   Currency Conversion 2.    Research
Methodology 3.    Executive Summary 4.  
 Global Epilepsy Drugs Market (2013 2025) 5.  
 Market Share Global Epilepsy Drugs (2013
2025) 5.1    By Country 5.2    By Drugs
Category 5.3    By Drugs 6.    Country - Global
Epilepsy Drugs Market Analysis (2013 2025) 6.1
   United States 6.2    United Kingdom 6.3  
 France6.4    Germany 6.5    Italy 6.6  
 Spain6.7    India 6.8    China 6.9  
 Japan

9
Key Topics Covered in Global Epilepsy Drugs Market
7.    By Drugs Category - Global Epilepsy Drugs
Market Analysis (2013 2025) 7.1    First
Generation 7.2    Second Generation 7.3  
 Third Generation 8.    By Drugs - Global
Epilepsy Drugs Market Analysis (2013 2025) 8.1
   Vimpat (Lacosamide) 8.2    Keppra
(Levetiracetam) 8.3    Sabril (Vigabatrin)8.4  
 Onfi (Clobazam) 8.5    Fycompa 8.6  
 Briviact (Brivaracetam)8.7    Epidiolex 8.8  
 Cenobamate (YKP3089) 9.    Growth Drivers 9.1
   Growing Awareness Programs Worldwide9.2  
 Presence of Promising Pipeline for Epilepsy
Therapeutics 10.    Challenges 10.1    New
Restrictions on Epilepsy Drug 10.2    High Cost
of Antiepileptic Drugs

10
Key Topics Covered in Global Epilepsy Drugs Market
11.    Eisai Co., Ltd. 11.1    Company
Overview 11.2    Initiatives/Activities11.3  
 Financial Insight 12.    UCB Inc. 12.1  
 Company Overview 12.2    Initiatives/Activities
12.3    Financial Insight 13.    H. Lundbeck
A/S 13.1    Company Overview 13.2  
 Initiatives/Activities13.3    Financial
Insight 14.    GW Pharmaceuticals Plc. 14.1  
 Company Overview 14.2    Initiatives/Activities
14.3    Financial Insight  

11
Global Epilepsy Drugs Market
If the information you seek is not included in
the current scope of the study kindly share your
specific requirements with our custom research
team at info_at_renub.com Browse Related Report
Allergic Conjunctivitis Market Global
Vitiligo Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
About PowerShow.com